Pancreatitis relapsing – Diagnostics – Overview of Information and Clinical Research

Relapsing pancreatitis is a challenging condition where episodes of pancreatic inflammation return again and again, causing severe pain and potentially leading to permanent damage. Understanding when to seek diagnostic testing and which methods doctors use can help patients get the right care at the right time.

Introduction: Who Should Undergo Diagnostics

If you experience recurring episodes of severe upper stomach pain, particularly pain that seems to come back after you thought you had recovered, it may be time to seek diagnostic testing for relapsing pancreatitis. This condition occurs when the pancreas becomes inflamed multiple times, and each new episode can bring back the intense discomfort you hoped was behind you.^[1]

Most people who have acute pancreatitis will experience only one episode in their lifetime and never face it again. However, if a child or adult has more than two episodes of acute pancreatitis, doctors diagnose them with acute recurrent pancreatitis, which is the medical term for when pancreatic inflammation keeps coming back.^[2] This distinction is important because recurrent episodes indicate something is triggering the pancreas repeatedly, and finding that trigger requires careful investigation.

You should consider seeking diagnostics if you notice a pattern of attacks happening over weeks, months, or years. Some patients experience relapses while still in the hospital receiving treatment for their initial attack, while others may go months or even years between episodes before symptoms return.^[7] Early diagnosis matters because repeated inflammation can eventually cause permanent scarring and damage to the pancreas, making it harder for your body to digest food properly and regulate blood sugar levels.^[2]

People at higher risk for developing relapsing pancreatitis include those who drink alcohol heavily, smoke tobacco, have gallstones, suffer from high levels of fats in their blood, or have certain genetic conditions. Men are more likely than women to develop chronic forms of pancreatitis, and the average age at diagnosis falls between 35 and 55 years.^[4] If you fall into any of these categories and experience repeated bouts of upper abdominal pain, nausea, vomiting, or fever, diagnostic testing can help determine whether relapsing pancreatitis is the cause.

⚠️ Important

Between 6,000 and 12,000 people in the UK receive a new diagnosis of chronic pancreatitis every year, though these numbers likely underestimate the true burden of the disease because early stages can be difficult to diagnose. About 8 out of 100 people who have acute pancreatitis may go on to develop the chronic, relapsing form of the disease. Seeking early diagnosis when symptoms first recur can help prevent progression to more serious complications.

Diagnostic Methods for Identifying Relapsing Pancreatitis

Initial Clinical Assessment

When you visit your doctor with suspected relapsing pancreatitis, the diagnostic process begins with a thorough discussion of your medical history and symptoms. Your healthcare provider will ask detailed questions about your pattern of pain—when it started, how often it returns, what makes it better or worse, and whether eating or drinking triggers the discomfort. They will also inquire about your alcohol consumption, smoking habits, family history of pancreatic disease, and any medications you take, as all these factors can contribute to recurring inflammation.^[4]

During the physical examination, your doctor will carefully feel your abdomen, checking for areas of tenderness or pain. The pancreas sits in the upper part of your belly behind the stomach, so pain in this region that spreads to your back is particularly concerning for pancreatitis. Your doctor may also check for signs of jaundice, a yellowing of the skin or eyes that can indicate bile duct problems related to pancreatic inflammation.^[20]

Blood Tests

Blood tests are among the first diagnostic tools used to confirm pancreatitis and distinguish it from other conditions. These tests look for elevated levels of two specific enzymes produced by the pancreas: amylase and lipase. When the pancreas becomes inflamed, these digestive enzymes leak into the bloodstream, causing their levels to rise significantly.^[16]

However, blood tests do more than just measure pancreatic enzymes. Your doctor will also check for signs of other complications or contributing factors. Tests may reveal elevated levels of fats in your blood called triglycerides, which can trigger pancreatitis when they become extremely high. Blood sugar levels help determine whether the pancreas is still producing enough insulin, as repeated inflammation can damage the insulin-producing cells. Liver function tests can show whether gallstones or bile duct problems might be causing the recurrent attacks.^[4]

In cases where autoimmune disease is suspected as the cause, blood tests can check for specific antibodies or elevated levels of a protein called IgG4, which indicates the immune system may be attacking the pancreas.^[8]

Imaging Studies

Imaging tests create detailed pictures of the pancreas and surrounding structures, helping doctors see inflammation, scarring, or blockages that blood tests cannot detect. Contrast-enhanced computed tomography, commonly known as a CT scan, is the best initial imaging study for diagnosing chronic pancreatitis. This test uses X-rays and computer processing to create three-dimensional images of your pancreas. The contrast material, injected through a vein, helps highlight blood vessels and tissues, making it easier to see areas of damage.^[4]

CT scans can reveal several telltale signs of relapsing pancreatitis. In advanced cases, the normal soft pancreatic tissue becomes irregular and hard, with scar tissue forming in inflamed areas. Calcium deposits may appear in these scarred regions, showing up as white spots on the scan. The bile ducts and pancreatic ducts may show narrowed sections called strictures or expanded segments. Sometimes fluid-filled cavities called pseudocysts develop around the pancreas after repeated inflammation.^[3]

However, CT scans have limitations. In the early stages of relapsing pancreatitis, the changes to the pancreas may be too subtle to detect. When CT results are unclear or inconclusive, doctors turn to other imaging methods for a clearer picture.^[4]

Magnetic resonance imaging (MRI) and a specialized version called magnetic resonance cholangiopancreatography (MRCP) use powerful magnets and radio waves instead of radiation to create detailed images. These tests are particularly good at showing the structure of the pancreatic ducts and bile ducts, helping doctors identify blockages or abnormalities that might be causing recurrent attacks. MRCP can visualize the entire duct system without requiring any invasive procedures.^[4]

Ultrasound imaging uses sound waves to create real-time pictures of internal organs. A standard abdominal ultrasound performed through the skin can show gallstones in the gallbladder or signs of inflammation in the pancreas. However, because the pancreas sits deep in the abdomen behind other organs and gas-filled intestines, regular ultrasound sometimes cannot get a clear view.^[20]

Endoscopic Procedures

Endoscopic ultrasonography (EUS) combines endoscopy with ultrasound technology to get extremely detailed images of the pancreas. During this procedure, a doctor passes a thin, flexible tube with a camera and ultrasound device through your mouth, down through your stomach, and into the upper part of your small intestine. Because the ultrasound probe is positioned right next to the pancreas, it provides much clearer images than ultrasound performed through the skin.^[4]

EUS is favored over another procedure called endoscopic retrograde cholangiopancreatography (ERCP) for diagnosing relapsing pancreatitis because it is safer and can evaluate both the pancreatic tissue itself and the duct system. During EUS, doctors can also perform a fine needle aspiration, using a thin needle to collect a small sample of pancreatic tissue or fluid from cysts for laboratory analysis.^[4]

When doctors find a cystic lesion or focal fluid collection during imaging, distinguishing between a harmless pseudocyst and a potentially dangerous cystic tumor becomes critical. Analysis of fluid taken from these cysts during EUS can provide important diagnostic clues. Laboratory tests on the fluid measure a protein called carcinoembryonic antigen (CEA), look at cells under a microscope to check for abnormalities, and search for specific DNA mutations that indicate a tumor rather than a simple fluid collection.^[12]

Stool and Pancreatic Function Tests

As relapsing pancreatitis progresses and causes more pancreatic damage, the organ may lose its ability to produce enough digestive enzymes. When this happens, your body cannot properly break down fats from food. Stool tests that measure fat levels can detect this problem, called steatorrhea. Finding high levels of fat in the stool suggests the pancreas is no longer functioning properly.^[4]

Pulmonary function testing and other specialized pancreatic function tests may be performed in some cases to assess how much digestive capacity remains. These tests help doctors determine whether enzyme replacement therapy might be needed and provide information about disease progression.^[20]

Distinguishing Relapsing Pancreatitis from Other Conditions

One of the most important aspects of diagnosis is making sure the recurrent pain actually comes from pancreatitis and not from another condition that mimics it. Many other digestive problems can cause similar upper abdominal pain, including gallbladder disease, stomach ulcers, gastroesophageal reflux disease, and irritable bowel syndrome. More seriously, pancreatic cancer can present with symptoms very similar to chronic pancreatitis, making careful evaluation essential.^[4]

The combination of elevated pancreatic enzymes during acute episodes, characteristic changes on imaging studies, and a pattern of recurring attacks helps doctors distinguish relapsing pancreatitis from these other conditions. When a focal mass or suspicious area appears on imaging, biopsy may be necessary to rule out cancer.^[12]

Diagnostics for Clinical Trial Qualification

When patients with relapsing pancreatitis consider participating in clinical trials testing new treatments, they must undergo specific diagnostic evaluations to determine their eligibility. Research studies require standardized criteria to ensure all participants have similar disease characteristics, making the results more reliable and meaningful. These qualification criteria are typically more detailed and stringent than routine clinical diagnostics.^[5]

Most clinical trials for recurrent acute pancreatitis require documented evidence of at least two separate episodes of acute pancreatitis. This documentation usually must include records showing elevated pancreatic enzyme levels during each episode, along with imaging studies confirming pancreatic inflammation. The time interval between episodes also matters—some trials may only accept patients whose attacks occurred within a certain timeframe.^[7]

Imaging requirements for trial enrollment are often more specific than for routine care. Many studies require participants to undergo contrast-enhanced CT scanning or MRI within a set period before enrollment to establish a baseline of pancreatic damage. Some trials specifically exclude patients who have already developed advanced chronic pancreatitis with extensive calcification or severe duct changes, focusing instead on those with earlier-stage disease where intervention might be most effective.^[10]

Blood tests for trial screening typically go beyond standard enzyme measurements. Researchers may check markers of ongoing inflammation, measure nutritional status through vitamin levels, assess liver function comprehensively, and perform genetic testing to look for hereditary forms of pancreatitis. Patients with certain genetic mutations may be specifically sought for some studies or excluded from others, depending on the research question.^[10]

Some clinical trials require endoscopic ultrasound evaluation before enrollment, particularly studies examining structural abnormalities or testing endoscopic interventions. This allows researchers to document the precise anatomy of the pancreatic ducts, identify any stones or strictures, and exclude patients with tumors or other lesions that might confound study results.^[4]

Functional testing of the pancreas may also be part of trial eligibility screening. This can include tests measuring how well the pancreas produces digestive enzymes and insulin. Trials studying enzyme replacement therapies or treatments for diabetes resulting from pancreatitis often require specific functional deficits as entry criteria.^[4]

Quality of life assessments and pain questionnaires are increasingly recognized as important trial enrollment criteria. Since many treatments aim to reduce pain and improve daily functioning, researchers need baseline measurements of these outcomes. Patients may be asked to complete detailed questionnaires about pain frequency, severity, and impact on activities, as well as surveys measuring depression, anxiety, and overall quality of life.^[5]

⚠️ Important

Clinical trials often have strict exclusion criteria regarding recent alcohol use or ongoing smoking. Since these behaviors significantly impact pancreatitis outcomes, researchers may require documentation of abstinence for a certain period before enrollment. Some studies require verification through blood tests or other objective measures, not just patient self-reporting. If you are interested in participating in a clinical trial, be prepared to discuss these habits honestly with the research team.

The diagnostic workup for trial qualification typically happens in addition to, not instead of, your regular medical care. Trial enrollment requires you to sign informed consent documents after understanding all the testing procedures, potential risks, and commitments involved. The research team will explain exactly which tests you need, why each test is necessary, and what the results must show for you to qualify for participation.^[5]

Prognosis and Survival Rate

Prognosis

The outlook for people with relapsing pancreatitis varies considerably depending on several factors, including the underlying cause, whether the triggers can be eliminated, and how much damage has already occurred to the pancreas. If the cause of recurrent attacks can be identified and addressed early—such as removing gallstones or stopping alcohol consumption—many patients can avoid further episodes and prevent progression to chronic pancreatitis with permanent damage.^[3]

However, between 10 to 40 percent of patients with recurrent acute pancreatitis will eventually develop chronic pancreatitis, a condition characterized by permanent scarring and loss of pancreatic function.^[18] Once chronic pancreatitis develops, the damage cannot be reversed, though treatments can help manage symptoms and complications. Patients who continue drinking alcohol or smoking face worse outcomes, with faster disease progression and increased risk of developing complications including diabetes and pancreatic cancer.^[5]

The risk of pancreatic cancer is increased in patients with chronic pancreatitis, especially those with hereditary forms of the disease. About 25 percent of patients with acute pancreatitis experience recurrence, and these recurring episodes significantly impact quality of life, often causing severe pain, requiring repeated hospitalizations, and leading to malnutrition when the pancreas loses its ability to produce digestive enzymes.^[7]

Patients with relapsing pancreatitis face ongoing challenges even between acute attacks. Many experience a continuous process of adaptation, struggling with dietary restrictions, medication regimens, and the uncertainty of when the next episode might occur. This psychological burden affects daily functioning and overall wellbeing.^[18]

Survival Rate

Survival rates for relapsing pancreatitis depend largely on the severity of acute episodes and whether life-threatening complications develop. Mild acute pancreatitis, which is usually self-limiting and recovers within 3 to 5 days, has a mortality rate of less than 1 percent. However, when severe acute pancreatitis develops during a relapse, the mortality rate can reach 30 to 40 percent.^[18]

The mortality rate of acute pancreatitis overall has remained relatively stable at about 10 percent despite advances in critical care medicine over the past 20 years.^[15] Patients who develop complications such as organ failure, severe infection, or necrotizing pancreatitis face significantly higher mortality risks. Hypertriglyceridemia-induced pancreatitis is associated with more severe outcomes than other causes, with higher rates of local complications, organ failure, and death.^[18]

Long-term survival for patients with chronic pancreatitis resulting from recurrent attacks depends on successful management of complications, particularly diabetes, malnutrition, and the increased cancer risk. There are more than 300,000 hospital admissions each year in the United States for acute pancreatitis, highlighting the significant healthcare burden of this condition.^[15] Early intervention, identification of triggering factors, and adherence to lifestyle modifications can significantly improve long-term outcomes and quality of life for people living with relapsing pancreatitis.

#1 Clinical Trials Search in Europe